openinnovation.astrazeneca.com的 10 大竞争对手

sygnaturediscovery.com

Discover emerging strategies that enhance drug delivery in next generation ADCs, opening new opportunities for improved clinical performance.

qmarkets.net

A data-led benchmark of how enterprises are building innovation capabilities, and the gap between what they invest and what they can prove.

ppd.com

Join us at Manor Country Club for an evening of fine dining and networking, plus a panel discussion on how to navigate the difficult biotech market we are

dctd.cancer.gov

This document sets out guiding principles for biobanking funded by the Cancer Moonshot initiatives.

genengnews.com

Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.

guidetopharmacology.org

the iuphar/bps guide to pharmacology. an expert-driven guide to pharmacological targets with quantitative information on the prescription medicines and experimental drugs that act on them. developed as a joint initiative of the international union of basic and clinical pharmacology (iuphar) and the british pharmacological society (bps) and is now the new home of the iuphar database (iuphar-db).

caymanchem.com

we manufacture high quality biochemicals, assay kits, antibodies, and recombinant proteins and offer contract services for custom chemical synthesis/analysis, assay development/screening, and drug discovery.

medchemexpress.com

MedChemExpress (MCE) provides 50,000+ selective Inhibitors and Recombinant Proteins with high purity and quality. Cited in 30,000+ publications by worldwide scientists.

selleckchem.com

Resiquimod (R-848, S28463) is an immune response modifier that acts as a potent TLR 7/TLR 8 agonist, inducing the upregulation of cytokines such as TNF-α, IL-6 and IFN-α. This compound reduces hepatitis C virus (HCV) infection. Phase 2.